| Profile | GDS1873 / 201899_s_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 1360.91 | 91 |
| GSM40788 | control - Rep 2 | 930.392 | 88 |
| GSM40789 | control - Rep 3 | 1120.66 | 90 |
| GSM40775 | androgen treated - Rep 1 | 1038.96 | 89 |
| GSM40776 | androgen treated - Rep 2 | 1344.3 | 92 |
| GSM40777 | androgen treated - Rep 3 | 1175.07 | 91 |
| GSM40790 | estrogen treated - Rep 1 | 1096.03 | 90 |
| GSM40791 | estrogen treated - Rep 2 | 1311.58 | 91 |
| GSM40792 | estrogen treated - Rep 3 | 1397.53 | 92 |
| GSM40784 | A + tamoxifen - Rep 1 | 1229.25 | 91 |
| GSM40785 | A + tamoxifen - Rep 2 | 1166.52 | 90 |
| GSM40786 | A + tamoxifen - Rep 3 | 1275.53 | 92 |
| GSM40778 | A + anastrozole - Rep 1 | 928.991 | 89 |
| GSM40779 | A + anastrozole - Rep 2 | 1257.48 | 90 |
| GSM40780 | A + anastrozole - Rep 3 | 1083.85 | 89 |
| GSM40781 | A + letrozole - Rep 1 | 716.838 | 85 |
| GSM40782 | A + letrozole - Rep 2 | 1041.18 | 89 |
| GSM40783 | A + letrozole - Rep 3 | 1149.64 | 90 |